Copegus Oral Tablet 200Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Copegus: Oral tablet (200mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_983.JPG
Copegus 200mg Tab
Genentech Inc
Pill Identification: RIB 200  |  ROCHE
Drug Image file DrugItem_8958.JPG
Ribavirin 200mg Tab
Teva Pharmaceuticals USA
Pill Identification: 93  |  7232
Drug Image file DrugItem_11604.JPG
Ribavirin 200mg Tab
Zydus Pharmaceuticals (USA) Inc
Pill Identification: ZC19 
Drug Image file DrugItem_13996.JPG
Ribavirin 200mg Tab
American Health Packaging
Pill Identification: ZC19 

What is this Medicine?

RIBAVIRIN (rye ba VYE rin) is an antiviral medicine. It is used with peginterferon alfa to treat hepatitis C. It will not work for colds, flu, or other viral infections.

In-Depth Information

Copegus 200mg Tablet

NDC: 000040086
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Sometimes used for but not FDA approved for the following conditions:
Lassa Fever Prophylaxis, Severe Acute Respiratory Syndrome (SARS), Hepatitis C Infection, Crimean-Congo Virus Hemorrhagic Fever (CCVHF) Prophylaxis, Encephalitis, West Nile Virus Infection

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Copegus 200mg Tablet
Drug Image file DrugItem_983.JPG
Genentech Inc
Pill Identification: RIB 200  |  ROCHE
Shape: oval
Color: pink

Reported Side Effects for Copegus 200mg Tablet

Overactive Thyroid Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Ulcer Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Moschcowitz Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot In Lung Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Sinus Infection Incidence:
<12.0%*
Severity: MILD
Onset: DELAYED
Metallic Taste Incidence:
<9.0%*
Severity: MILD
Onset: EARLY
Low Platelet Count Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Thoughts Of Suicide Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
<12.0%*
Severity: MILD
Onset: DELAYED
Psychosis Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Nerve Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Diabetes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Aplastic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Cholangitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Coma Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Hallucinations Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
<16.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Depression Incidence:
1.0-36.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
1.0-33.0%*
Severity: MODERATE
Onset: DELAYED
Blurred Vision Incidence:
2.0-6.0%*
Severity: MODERATE
Onset: EARLY
Irritability Incidence:
3.0-47.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
3.0-47.0%*
Severity: MILD
Onset: DELAYED
Flushing Incidence:
3.0-4.0%*
Severity: MILD
Onset: RAPID
Emotional Lability Incidence:
3.0-47.0%*
Severity: MILD
Onset: EARLY
Conjunctivitis Incidence:
4.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Enlarged Liver Incidence:
>4.0%*
Severity: MODERATE
Onset: DELAYED
Feeling Sick Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
Eczema Vaccinatum Incidence:
4.0-5.0%*
Severity: SEVERE
Onset: DELAYED
Dry Mouth Incidence:
4.0-12.0%*
Severity: MILD
Onset: EARLY
Underactive Thyroid Incidence:
4.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
5.0-29.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
5.0-26.0%*
Severity: MODERATE
Onset: EARLY
Constipation Incidence:
>5.0%*
Severity: MODERATE
Onset: DELAYED
Chest Pain Incidence:
5.0-9.0%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
>5.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
5.0-68.0%*
Severity: MILD
Onset: DELAYED
Injection Site Reaction Incidence:
5.0-58.0%*
Severity: MILD
Onset: RAPID
Distressed Incidence:
5.0-8.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cell Counts Incidence:
5.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Irregular Periods Incidence:
6.0-7.0%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
6.0-8.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
8.0-21.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
9.0-42.0%*
Severity: MILD
Onset: EARLY
Hemolytic Anemia Incidence:
10.0-13.0%*
Severity: SEVERE
Onset: DELAYED
Weight Loss Incidence:
10.0-29.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
10.0-22.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
11.0-67.0%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
12.0-13.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
12.0-29.0%*
Severity: MILD
Onset: RAPID
Low Lymphocytes Incidence:
12.0-14.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
13.0-26.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
14.0-41.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
15.0-34.0%*
Severity: MILD
Onset: DELAYED
Hair Loss Incidence:
17.0-36.0%*
Severity: MILD
Onset: DELAYED
Muscle Pain Incidence:
17.0-64.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
18.0-47.0%*
Severity: MILD
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
19.0-28.0%*
Severity: MILD
Onset: EARLY
Chills Incidence:
21.0-39.0%*
Severity: MILD
Onset: RAPID
Fever Incidence:
21.0-80.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
21.0-51.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
30.0-70.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
41.0-69.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Second Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Third Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Copegus

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5